Assessment and Management of Hepatobiliary Disease

Front Matter....Pages I-XII
Front Matter....Pages 1-1
Liver Transplantation: State of the Art....Pages 3-8
Mathematical Models for the Study of Hepatic Metabolism: A New Strategy....Pages 9-12
Mechanism of Hepatic Fatty Acid Uptake....Pages 13-22
Vesicular Transport of Fluid Phase Markers by Hepatocytes....Pages 23-30
The Hepatic Uptake of Organic Anions: An Overview....Pages 31-40
Mechanisms of Transport of Tauroconjugated Bile Acids in the Hepatocyte: Functional Significance....Pages 41-48
Determinants of Biliary Cholesterol Secretion....Pages 49-58
The Enterohepatic Circulation of Sulfated and Nonsulfated Bile Acids....Pages 59-65
Estrogens and Bile Secretion....Pages 67-73
Transport of UDPG in Vitro and Reversal of Ethanol-Induced Effects....Pages 75-82
Associated Factors in Gallstone Disease....Pages 83-88
Epidemiology of Gallstone Disease in Hungary....Pages 89-94
The Role of the Gallbladder in Cholesterol Gallstone Pathogenesis....Pages 95-103
Mechanism of Gallstone Formation in Obese Subjects....Pages 105-106
Medical Treatment of Cholesterol Gallstones: Present and Future....Pages 107-114
Bile Acid Treatment of Cholesterol Gallstones: A Reappraisal....Pages 115-123
Biliary Lipid Composition after Endoscopic Sphincterotomy in Postcholecystectomy Patients: Effect of Short-Term Ursodeoxycholic Acid Administration....Pages 125-131
Concluding Remarks....Pages 133-134
Front Matter....Pages 135-135
Drug-Induced Liver Injury....Pages 137-144
Biochemical Liver Tests: Recent Developments and Challenges....Pages 145-155
Front Matter....Pages 135-135
Should Serum Bile Acid Determinations Be Performed Routinely in Patients with Liver Disease?....Pages 157-161
Clinical Significance of Serum Bilirubins: Recent Advances....Pages 163-169
Enzyme Pattern Changes in Preneoplastic and Neoplastic Lesions of the Liver....Pages 171-186
The Value of Quantitation of Liver Function....Pages 187-188
Quantitation of Liver Function: Antipyrine Metabolism, an Update....Pages 189-195
Antipyrine Clearance: Evaluation of Simplified Methods in Chronic Liver Diseases....Pages 197-204
Preoperative Care of Adult Patients Chosen for Liver Transplantation....Pages 205-208
Assessment of Liver Function Before and After Liver Transplantation....Pages 209-216
Hormones and Liver: Some Aspects of the Problem....Pages 217-225
Effects of Thyroid Hormone Administration and of Thyroidectomy on the Metabolism of Bilirubin in Rats....Pages 227-233
Comparison of Some Parameters of the Drug-Metabolizing Enzyme System and Liver Function Tests in Different Hepatic Diseases....Pages 235-246
Interaction of Ethanol with Hepatic Drug Metabolism....Pages 247-255
Antioxidant and Immunomodulant Effect of Hepatoprotective Drugs....Pages 257-263
Stimulating Influence of a Flavonolignane Derivative on Proliferation, RNA Synthesis and Protein Synthesis in Liver Cells....Pages 265-272
Renal Functional Impairment in Cirrhosis....Pages 273-279
Pathophysiology of Cirrhotic Ascites....Pages 281-289
Treatment of Ascites....Pages 291-295
Low-Sodium Diet in the Management of Ascites in the Cirrhotic Patient....Pages 297-302
Treatment of Refractory Ascites by Concentrated Ascitic Fluid Reinfusion....Pages 303-307
Concluding Remarks....Pages 309-311
Front Matter....Pages 313-313
Liver and Aging....Pages 315-320
Prognosis of Advanced Liver Disease....Pages 321-327
Virus and Host Factors in the Evolution of Chronic Hepatitis Type B: Choice of Treatment....Pages 329-336
Antiviral Treatment of Chronic Hepatitis....Pages 337-344
Autoimmune Hepatitis: Diagnosis and Treatment....Pages 345-348
Serum β 2 -Microglobulin and Anti- β 2 m Antibodies in Chronic Liver Disease....Pages 349-354
Treatment of Liver Cirrhosis....Pages 355-364
Drug Therapy for Alcoholic Liver Disease....Pages 365-376
Silymarin Treatment in Patients with Cirrhosis of the Liver — a Prospective Study....Pages 377-383
Protein Malnutrition in Chronic Liver Disease: Corrective Measures....Pages 385-395
The Management of Primary Biliary Cirrhosis....Pages 397-404
Impaired Calcitonin Response to Intravenous Calcium Load in Primary Biliary Cirrhosis....Pages 405-407
Prevention of Upper Gastrointestinal Bleeding in Cirrhotic Patients....Pages 409-415
Prophylactic Treatment of First Variceal Bleeding in Cirrhotics with Nadolol or Ranitidine: A Prospective Randomized Study....Pages 417-421
Hemodynamic and Clinical Evaluation of Nadolol in the Treatment of Portal Hypertension in Patients with Cirrhosis....Pages 423-430
The GABA Hypothesis of the Pathogenesis of Hepatic Encephalopathy: Current Status....Pages 431-435
Lactitol in the Prevention of Recurrent Hepatic Encephalopathy in Shunted Cirrhotic Patients. Preliminary Results of a Controlled Trial....Pages 437-440
Concluding Remarks....Pages 441-445
Back Matter....Pages 447-452